Search
Displaying 271–280 of 790 for “retinitis clinical trial”
-
Staying Alive: Saving Retinal Cells to Preserve Vision
Research NewsSometimes, saving vision simply comes down to keeping retinal cells alive, or at least slowing their degeneration.
-
Could Combining Future Treatments Be an Option?
Research NewsHow therapies will likely be used synergistically in the future.
-
Beacon Stories
Since becoming involved with the Foundation Fighting Blindness 10 years ago, Brenda has become a dedicated leader, advocate and champion for the community. Whether welcoming someone newly diagnosed, leading the Fort Wayne Chapter or participating in a clinical trial to help advance research, Brenda has dedicated herself to creating more hope and opportunity for others.
-
Foundation News
The award recognizes Dr. Pierce’s contributions to inherited retinal disease research, including work that led to the first FDA-approved gene therapy for an inherited disease and leadership of the world’s first in vivo CRISPR genome-editing study in humans.
-
Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for its Optogenetic Therapy
Research NewsThe company plans to complete BLA submission in early 2026.
-
Disease
Rare retinal conditions are a group of disorders that affect the retina and occur at a low frequency in the population. Based on regulatory definitions, in the United States, a rare retinal condition affects fewer than 200,000 individuals nationwide, consistent with the FDA Orphan Drug Act definition of a rare disease. In the European Union, a rare retinal condition affects fewer than 1 in 2,000 people, in accordance with the European Medicines Agency (EMA) criteria. These conditions collectively impact small, often genetically defined patient populations, despite being numerous and highly diverse.
-
FFB Congratulates RPE65 Gene Therapy Researchers for Champalimaud Award
Research NewsOn September 4, 2018, seven researchers, including six previously funded by the Foundation, were recognized with the prestigious 2018 Antonio Champalimaud Vision Award for their contributions to the advancement of blindness-reversing RPE65 gene therapies.
-
Research News
An advisory committee comprised of FDA-selected experts voted unanimously – 16 to 0 – to recommend approval.
-
SparingVision Formed to Advance Sight-Saving Protein for RP
Research NewsSparingVision received a €300,000 award known as the Honor Prize from the French Ministry of Research. The award is given to new, innovative companies in France competing in a national contest.
-
Resources for Eye Care Professionals
Resources to help eye care professionals evaluate, refer and support patients with inherited retinal diseases or age-related macular degeneration, including genetic testing, clinical trials and patient support from the Foundation Fighting Blindness.
